Biomarkers of cardiovascular disease: contributions to risk prediction in individuals with diabetes.

about

Biomarkers of cardiovascular disease: contributions to risk prediction in individuals with diabetes.

Item

http://www.wikidata.org/entity/Q49691813

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Biomarkers of cardiovascular d ...... in individuals with diabetes.

@en

Biomarkers of cardiovascular d ...... in individuals with diabetes.

@nl

type

Item

label

Biomarkers of cardiovascular d ...... in individuals with diabetes.

@en

Biomarkers of cardiovascular d ...... in individuals with diabetes.

@nl

prefLabel

Biomarkers of cardiovascular d ...... in individuals with diabetes.

@en

Biomarkers of cardiovascular d ...... in individuals with diabetes.

@nl

P1476

Biomarkers of cardiovascular d ...... in individuals with diabetes.

@en

P2093

Katherine N Bachmann

http://www.w3.org/2001/XMLSchema#string

P2860

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

Simple non-invasive assessment of advanced glycation endproduct accumulation

Translating clinical research into clinical practice: impact of using prediction rules to make decisions

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

General cardiovascular risk profile for use in primary care: the Framingham Heart Study

Metabolite profiles and the risk of developing diabetes

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

SAVOR-TIMI to SUSTAIN-6: a critical comparison of cardiovascular outcome trials of antidiabetic drugs.

Use of Biomarkers in Predicting the Onset, Monitoring the Progression, and Risk Stratification for Patients with Type 2 Diabetes Mellitus.

P2888

s00125-017-4442-9

P304

987-995

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00125-017-4442-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Thomas J Wang

P577

2017-09-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091971918

http://www.w3.org/2001/XMLSchema#string

P698

28956084

http://www.w3.org/2001/XMLSchema#string

P932

5874155

http://www.w3.org/2001/XMLSchema#string